BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND CALCB, Calcitonin AND Prognosis
167 results:

  • 1. Hsp70 and calcitonin Receptor Protein in Extracellular Vesicles from Glioblastoma Multiforme: Biomarkers with Putative Roles in Carcinogenesis and Potential for Differentiating tumor Types.
    Alberti G; Sánchez-López CM; Marcilla A; Barone R; Caruso Bavisotto C; Graziano F; Conway de Macario E; Macario AJL; Bucchieri F; Cappello F; Campanella C; Rappa F
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542389
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Measuring discrepancies between simple medullary and synchronous medullary/papillary thyroid carcinomas: a comparative cross-sectional study.
    Zhang D; Yang M; Frattini F; Cestari A; Li K; Wang H; Chi H; Sui C; Bai K; Lan D; Dionigi G; Sun H
    Front Endocrinol (Lausanne); 2023; 14():1301200. PubMed ID: 38317715
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Precision medicine in endocrinology exemplified by medullary thyroid cancer].
    Brandenburg T; Machlah YM; Führer D
    Inn Med (Heidelb); 2024 Mar; 65(3):202-210. PubMed ID: 38231404
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Risk factors for cervical lymph node metastasis in the central or lateral cervical region in medullary thyroid carcinoma: a systematic review and meta-analysis.
    Lin X; Huo J; Su H; Zhu C; Xu Y; Zhang F
    Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):547-561. PubMed ID: 37801162
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Severe hypercalcemia due to metastatic pancreatic neuroendocrine tumor: a case report.
    Behdadnia A; Jeddi M
    J Med Case Rep; 2023 Sep; 17(1):400. PubMed ID: 37670372
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Appropriate and mindful measurement of serum calcitonin in patients with thyroid nodules. A white paper.
    Trimboli P; Valderrabano P; Pitoia F; Piccardo A; Bojunga J
    Endocrine; 2024 Jan; 83(1):60-64. PubMed ID: 37589814
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Medullary Thyroid Cancer: Updates and Challenges.
    Gild ML; Clifton-Bligh RJ; Wirth LJ; Robinson BG
    Endocr Rev; 2023 Sep; 44(5):934-946. PubMed ID: 37204852
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma.
    Kesby N; Mechera R; Fuchs T; Papachristos A; Gild M; Tsang V; Clifton-Bligh R; Robinson B; Sywak M; Sidhu S; Chou A; Gill AJ; Glover A
    J Clin Endocrinol Metab; 2023 Sep; 108(10):2626-2634. PubMed ID: 36964913
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Hereditary medullary thyroid cancer].
    Fendrich V; Zahn A
    Chirurgie (Heidelb); 2023 May; 94(5):393-399. PubMed ID: 36799965
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Other markers of medullary thyroid cancer, not only calcitonin.
    Censi S; Manso J; Mian C
    Eur J Endocrinol; 2023 Jan; 188(1):. PubMed ID: 36651167
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Nociceptor neurons affect cancer immunosurveillance.
    Balood M; Ahmadi M; Eichwald T; Ahmadi A; Majdoubi A; Roversi K; Roversi K; Lucido CT; Restaino AC; Huang S; Ji L; Huang KC; Semerena E; Thomas SC; Trevino AE; Merrison H; Parrin A; Doyle B; Vermeer DW; Spanos WC; Williamson CS; Seehus CR; Foster SL; Dai H; Shu CJ; Rangachari M; Thibodeau J; V Del Rincon S; Drapkin R; Rafei M; Ghasemlou N; Vermeer PD; Woolf CJ; Talbot S
    Nature; 2022 Nov; 611(7935):405-412. PubMed ID: 36323780
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. An Undetectable Postoperative calcitonin Level Is Associated with Long-Term Disease-Free Survival in Medullary Thyroid Carcinoma: Results of a Retrospective Cohort Study.
    Duval MADS; Ferreira CV; Marmitt L; Dora JM; Espíndola M; Benini AF; Camelier MV; Bulzico D; Andrade FA; Alves Júnior PA; Corbo R; Vaisman F; Zanella AB; Scheffel RS; Maia AL
    Thyroid; 2023 Jan; 33(1):82-90. PubMed ID: 36222615
    [No Abstract]    [Full Text] [Related]  

  • 13. A Rare Case of Negative Serum calcitonin in Metastatic Medullary Thyroid Carcinoma: Diagnosis, Treatment, and Follow-Up Strategy.
    Licata L; Di Fidio CA; Vacante M; Basile F; Biondi A; Richiusa P; Gurrera A; Ciuni R
    Am J Case Rep; 2022 Sep; 23():e935207. PubMed ID: 36088532
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. RREB1 promotes the development of parafollicular carcinogenesis through the Ras-Raf-1-ELK3 signaling pathway.
    Ma S; Wang H; Li W; Yan Z; Luo X; Lu P
    Nucleosides Nucleotides Nucleic Acids; 2022; 41(10):972-981. PubMed ID: 35737446
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Is Encapsulated Medullary Thyroid Carcinoma Associated With a Better prognosis? A Case Series and a Review of the Literature.
    Contarino A; Dolci A; Maggioni M; Porta FM; Lopez G; Verga U; Elli FM; Iofrida EF; Cantoni G; Mantovani G; Arosio M
    Front Endocrinol (Lausanne); 2022; 13():866572. PubMed ID: 35574005
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The GIP/GIPR axis in medullary thyroid cancer: clinical and molecular findings.
    Regazzo D; Bertazza L; Galletta E; Barollo S; Mondin A; Zovato S; Iacobone M; Zilio E; Scaroni C; Radu CM; di Benedetto G; Mian C; Lefkimmiatis K; Occhi G
    Endocr Relat Cancer; 2022 Apr; 29(5):273-284. PubMed ID: 35298396
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Incidental T1 stage medullary thyroid carcinoma: The effect of tumour diameter on prognosis and therapeutic implications.
    Gui Z; Wang Z; Xiang J; Sun W; He L; Dong W; Huang J; Zhang D; Lv C; Zhang T; Shao L; Zhang P; Zhang H
    Clin Endocrinol (Oxf); 2022 Sep; 97(3):355-362. PubMed ID: 35192214
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Utilizing the circulating tumor markers in diagnosis and management of medullary thyroid cancer.
    Zarkesh M; Arab N; Tavangar SM; Nozhat Z; Fanaei SM; Hedayati M
    Pathol Res Pract; 2022 Jan; 229():153694. PubMed ID: 34929598
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Preoperative calcitonin testing improves the diagnosis of medullary thyroid carcinoma in female and male patients.
    Weber T; Poplawski A; Vorländer C; Dotzenrath C; Ringelband R; Schabram J; Passler C; Zielke A; Schlegel N; Nies C; Krenz D; Jähne J; Schwab R; Bartsch DK; Binnebösel M; Kemen M; Klinger C; Buhr H; Lorenz K
    Eur J Endocrinol; 2022 Jan; 186(2):223-231. PubMed ID: 34871180
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Medullary thyroid carcinoma: current clinical progress].
    Kroiss M; Koehler VF; Spitzweg C
    Dtsch Med Wochenschr; 2021 Nov; 146(23):1527-1532. PubMed ID: 34826838
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 9.